Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-80.26	-51.72	-28.69
Graham Fair Price	-15.25	2630.20	3103.52
PEG	1958.11	0.22	-0.01
Price/Book	-4.65	0.42	0.44
Price/Cash Flow	-25.55	-3.23	4.34
Prices/Earnings	-27.17	-5.87	-4.61
Price/Sales	-10.39	0.50	0.56
Price/FCF	-25.55	-3.23	4.34
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-42.62	0.16	0.28
Operating Margin	30.15	-0.02	-0.03
ROA	29.89	< 0.005	-0.01
ROE	-0.02	-0.02	25.03
ROIC	-0.01	-0.01	5.70
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.64	-0.29	120.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.18	0.27	-87.52
EPS QOQ	-4.31	0.27	-93.82
FCF QOQ	3.08	-2.25	-26.79
Revenue QOQ	-0.02	0.04	70.18
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	58.68	45.64	-22.23
Days Sales Outstanding (DSO)	91.10	96.98	6.45
Inventory Turnover	1.53	1.97	28.58
Debt/Capitalization	0.16	0.24	45.43
Quick Ratio	0.98	0.96	-2.71
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4253.70	4163.36	-2.12
Cash	363.19	344.44	-5.16
Capex	-12.43	-99.67	-702.00
Free Cash Flow	427.61	-536.01	25.35
Revenue	3325.20	3463.04	4.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.43	1.35	-5.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.80	-19.22	-231.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating